Back

Efficacy of flecainide in patients with high premature ventricular contractions burden and previous b-blocker failure: a UNIFLECA sub-analysis

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Diagnosis and management of premature ventricular contractions Drug Treatment of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sotirios Kotoulas

Asklepieion Voulas General Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Efficacy and safety of a sandwich ablation strategy for idiopathic PVCs: insights from a propensity-matched cohort
Doctor E. Ozcan Cetin (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of idiopathic premature ventricular contractions in athletes without structural heart disease: impact on arrhythmic burden and return to sport
Doctor F. Cardinali (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Non-invasive Predictors of recurrence after catheter ablation for idiopathic PVCs
Doctor H. Yalman (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
AI-based differential diagnosis and localization of idiopathic PVC using 12-lead ECG: multicenter registry study (EP-AI ASSIST)
Doctor C. Seo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Comparative diagnostic performance of electrocardiographic- derived algorithms in identifying the site of origin of idiopathic outflow tract originating ventricular premature complexes
Doctor M. Botis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and management of premature ventricular contractions

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Flecainide in the treatment of high premature ventricular contractions burden: preliminary results from the UNIFLECA study
thumbnail
Congress Presentation
Effect of flecainide on complex ventricular arrhythmogenesis: insights from the prospective UNIFLECA study
thumbnail
Congress Presentation
Efficacy and safety of flecainide in patients with reduced ejection fraction and high premature ventricular complex burden: a single-center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources